Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

to collect real life data on the use of fulvestrant in clinical practice in Belgium. Previous therapies (hormonal and chemo) for breast cancer and for advanced breast cancer will be documented for each patient.

Outcome Time Frame:

Visit 1, Visit 2

Safety Issue:

Yes

Principal Investigator

Neven P Prof

Investigator Role:

Study Director

Investigator Affiliation:

KUL

Authority:

Belgium: Federal Agency for Medicinal Products and Health Products

Study ID:

NIS-OBE-FAS-2008/1

NCT ID:

NCT00735215

Start Date:

October 2008

Completion Date:

December 2009

Related Keywords:

• Metastatic Breast Cancer
• Breast cancer,
• fulvestrant,
• postmenopausal,
• women
• locally advanced,
• hormone receptor-positive.
• Breast Neoplasms

Name	Location